Robotic mitral valve repair: A single center experience over a 7-year period.


Journal

Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809

Informations de publication

Date de publication:
Aug 2022
Historique:
revised: 21 08 2021
received: 03 07 2021
accepted: 23 09 2021
pubmed: 6 5 2022
medline: 6 7 2022
entrez: 5 5 2022
Statut: ppublish

Résumé

We report the clinical and echocardiographic results of our experience in robotic mitral valve repair over a 7-year period. The outcomes of the earliest and the latest patients will be compared. Between March 2012 and October 2019, 226 patients underwent robotic mitral valve repair for severe mitral regurgitation in a single institution. The first 113 patients (Group 1) were operated between March 2012 and September 2015 and the last 113 patients (Group 2) between October 2015 and October 2019. Conventional techniques employed in open surgery were used. Clinical and echographic follow-up were 96.0% and 94.2% complete, respectively. Successful mitral repair was achieved in all cases with no hospital mortality. The overall survival rate was 92.7 ± 2.8% and 91.0 ± 3.2% at 3 and 7 years, respectively, with no in between groups difference (p = 0.513). The overall freedom from mitral reoperation was 97.4 ± 1.2% at 3 and 7 years and was similar in both groups (p = 0.276). Freedom from mitral regurgitation Grade 2+ at 3 and 7 years were 89.1 ± 2.6% and 87.9 ± 2.8%, respectively, with no significant difference between groups (p = 0.056). Developing a robotic mitral repair program can be done without compromising the safety and efficacy of repair. After a well-conducted training, robotic approach allows to perform simple and complex mitral repair using similar techniques as in conventional approach and without additional risk for the patient.

Sections du résumé

BACKGROUND BACKGROUND
We report the clinical and echocardiographic results of our experience in robotic mitral valve repair over a 7-year period. The outcomes of the earliest and the latest patients will be compared.
METHODS METHODS
Between March 2012 and October 2019, 226 patients underwent robotic mitral valve repair for severe mitral regurgitation in a single institution. The first 113 patients (Group 1) were operated between March 2012 and September 2015 and the last 113 patients (Group 2) between October 2015 and October 2019. Conventional techniques employed in open surgery were used. Clinical and echographic follow-up were 96.0% and 94.2% complete, respectively.
RESULTS RESULTS
Successful mitral repair was achieved in all cases with no hospital mortality. The overall survival rate was 92.7 ± 2.8% and 91.0 ± 3.2% at 3 and 7 years, respectively, with no in between groups difference (p = 0.513). The overall freedom from mitral reoperation was 97.4 ± 1.2% at 3 and 7 years and was similar in both groups (p = 0.276). Freedom from mitral regurgitation Grade 2+ at 3 and 7 years were 89.1 ± 2.6% and 87.9 ± 2.8%, respectively, with no significant difference between groups (p = 0.056).
CONCLUSIONS CONCLUSIONS
Developing a robotic mitral repair program can be done without compromising the safety and efficacy of repair. After a well-conducted training, robotic approach allows to perform simple and complex mitral repair using similar techniques as in conventional approach and without additional risk for the patient.

Identifiants

pubmed: 35510407
doi: 10.1111/jocs.16575
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2266-2277

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022 Wiley Periodicals LLC.

Références

Carpentier A. Cardiac valve surgery-the “French correction”. J Cardiovasc Surg. 1983;86(3):323-337.
Richardson L, Richardson M, Hunter S. Is a port-access mitral valve repair superior to the sternotomy approach in accelerating postoperative recovery? Interact Cardiovasc Thorac Surg. 2008;7:678-683.
Carpentier A, Loulmet D, Carpentier A, et al. Open heart operation under videosurgery and minithoracotomy. First case (mitral-valvuloplasty) operated with success. C R Acad Sci III. 1996;319:219-223.
Carpentier A, Loulmet D, Aupècle B, et al. Computer assisted open heart surgery. First case operated on with success. C R Acad Sci III. 1998;321:437-442.
Fujita T, Kakuta T, Kawamoto N, et al. Benefits of robotically-assisted surgery for complex mitral valve repair. Interact Cardiovasc Thorac Surg. 2020;32:417-425. doi:10.1093/icvts/ivaa271
Ramzy D, Chung J, Cheng W, De Robertis MA, Mirocha J, Trento A. Complex robotic correction for complex degenerative mitral valve disease. Ann Cardiothorac Surg. 2017;6(1):70-72.
Otto C, Nishimura R, Bonow R, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association K-Joint Committee on Clinical Practice Guidelines. Circulation. 2020;143(5):407-409.
Gillinov AM, Mihaljevic T, Javadikasgari H, et al. Early results of robotically assisted mitral valve surgery: analysis of first 1000 cases. J Thorac Cardiovasc Surg. 2018;155:82-91.
Navarra E, Mastrobuoni S, de Kerchove L, et al. Robotic mitral valve repair: a European single-center experience. Interact Cardiovasc Thorac Surg. 2017;25(1):62-67.
Akins CW, Miller DC, Turina MI, et al. Guidelines for reporting mortality and morbidity after cardiac valve interventions. Ann Thorac Surg. 2008;85(4):1490-1495.
Liu G, Zhang H, Yang M, et al. Robotic mitral valve repair: 7-year surgical experience and mid-term follow-up results. J Cardiovasc Surg. 2019;60(3):406-412.
Galloway AC, Schwartz CF, Ribakove GH, et al. A decade of minimally invasive mitral repair: long term outcomes. Ann Thorac Surg. 2009;88:1180-1184.
Marin Cuartas M, Javadikasgari H, Pfannmueller B, et al. Mitral valve repair: robotic and other minimally invasive approaches. Prog Cardiovasc Dis. 2017;60(3):394-404.
Javadikasgari H, Suri RM, Tappuni B, et al. Robotic mitral valve repair for degenerative posterior leaflet prolapse. Ann Cardiothorac Surg. 2017;6(1):27-32.
Seeburger J, Borger MA, Falk V, et al. Minimal invasive mitral valve repair for mitral regurgitation: results of 1339 consecutive patients. Eur J Cardiothoracic Surg. 2008;34:760-765.
Chitwood W. Robotic mitral valve surgery: overview, methodology, results, and perspective. Ann Cardiothorac Surg. 2016;5(6):544-555.
Takagi H, Hari Y, Nakashima K, Kuno T, Ando T. Meta-analysis of propensity matched studies of robotic versus conventional mitral valve surgery. J Cardiol. 2020;75(2):177-181.
Mihaljevic T, Pattakos G, Gillinov AM, et al. Robotic posterior mitral leaflet repair: neochordal versus resectional techniques. Ann Thorac Surg. 2013;95(3):787-794.
Pettinari M, Navarra E, Noirhomme P, Gutermann H. The state of robotic cardiac surgery in Europe. Ann Cardiothorac Surg. 2017;6(1):1-8.
Goodman A, Koprivanac M, Kelava M, et al. Robotic mitral valve repair: the learning curve. Innovations. 2017;12(6):390-397.

Auteurs

Maureen Klepper (M)

Cardiovascular Research Center, Institute for Experimental and Clinical Research, Catholic University of Louvain, Brussels, Belgium.
Department of Cardiovascular and Thoracic Surgery, Saint-Luc University Clinics, Catholic University of Louvain, Brussels, Belgium.

Philippe Noirhomme (P)

Cardiovascular Research Center, Institute for Experimental and Clinical Research, Catholic University of Louvain, Brussels, Belgium.
Department of Cardiovascular and Thoracic Surgery, Saint-Luc University Clinics, Catholic University of Louvain, Brussels, Belgium.

Laurent de Kerchove (L)

Cardiovascular Research Center, Institute for Experimental and Clinical Research, Catholic University of Louvain, Brussels, Belgium.
Department of Cardiovascular and Thoracic Surgery, Saint-Luc University Clinics, Catholic University of Louvain, Brussels, Belgium.

Stefano Mastrobuoni (S)

Cardiovascular Research Center, Institute for Experimental and Clinical Research, Catholic University of Louvain, Brussels, Belgium.
Department of Cardiovascular and Thoracic Surgery, Saint-Luc University Clinics, Catholic University of Louvain, Brussels, Belgium.

Cristiano Spadaccio (C)

Department of Cardiovascular and Thoracic Surgery, Saint-Luc University Clinics, Catholic University of Louvain, Brussels, Belgium.
Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.

Guillaume Lemaire (G)

Department of Anesthesiology, Saint-Luc University Clinics, Catholic University of Louvain, Brussels, Belgium.

Gébrine El Khoury (G)

Cardiovascular Research Center, Institute for Experimental and Clinical Research, Catholic University of Louvain, Brussels, Belgium.
Department of Cardiovascular and Thoracic Surgery, Saint-Luc University Clinics, Catholic University of Louvain, Brussels, Belgium.

Emiliano Navarra (E)

Cardiovascular Research Center, Institute for Experimental and Clinical Research, Catholic University of Louvain, Brussels, Belgium.
Department of Cardiovascular and Thoracic Surgery, Saint-Luc University Clinics, Catholic University of Louvain, Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH